UnitedHealth Group (NYSE:UNH) Stock Price Down 0.8%

Shares of UnitedHealth Group Incorporated (NYSE:UNHGet Free Report) traded down 0.8% on Wednesday . The stock traded as low as $480.71 and last traded at $482.31. 1,207,368 shares traded hands during trading, a decline of 73% from the average session volume of 4,499,818 shares. The stock had previously closed at $486.18.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Bank of America restated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. TD Cowen cut their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Barclays boosted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Finally, Piper Sandler upped their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $570.05.

Check Out Our Latest Report on UNH

UnitedHealth Group Stock Performance

The company’s fifty day simple moving average is $487.49 and its 200 day simple moving average is $514.76. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $449.26 billion, a price-to-earnings ratio of 29.48, a P/E/G ratio of 1.42 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the business posted $6.26 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.54%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of UNH. Norges Bank bought a new position in UnitedHealth Group in the fourth quarter worth approximately $5,802,231,000. International Assets Investment Management LLC lifted its stake in UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after acquiring an additional 2,348,107 shares in the last quarter. Jennison Associates LLC raised its holdings in shares of UnitedHealth Group by 49.3% in the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after purchasing an additional 1,195,352 shares during the last quarter. Mawer Investment Management Ltd. boosted its holdings in UnitedHealth Group by 75.0% during the third quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock worth $1,014,002,000 after purchasing an additional 862,024 shares during the last quarter. Finally, California Public Employees Retirement System increased its stake in UnitedHealth Group by 35.9% in the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after buying an additional 815,822 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.